MD — Pediatrix Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $1.70bn
- $1.80bn
- $1.91bn
Annual cashflow statement for Pediatrix Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 131 | 66.3 | -60.4 | -99.1 | 165 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -31.8 | 55.9 | 170 | 187 | -10.1 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -23.4 | 31.8 | -11.6 | 88.2 | 41.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 76.7 | 167 | 137 | 207 | 271 |
| Capital Expenditures | -32.2 | -29.7 | -33.3 | -22 | -18.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -20.8 | -27.2 | -14.8 | -13.4 | 0.162 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -53.1 | -57 | -48.2 | -35.4 | -18.3 |
| Financing Cash Flow Items | 0.407 | 0.732 | -10.6 | -1.03 | -3.25 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -760 | -488 | -25.7 | -14.5 | -107 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -736 | -378 | 63.4 | 157 | 145 |